Expression Table for this CRE
| CNhs13844 | iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2 | 3.1 |
| LShi10030_ACAGTG-CACTATG | Human induced pluripotent stem cells grown on feeder-free condition, biol_rep3 | 3.1 |
| CNhi10525_AGT | Human primary dermal fibroblasts derived from neonatal foreskin, biol_rep1 | 2.3 |
| CNhs11990 | Smooth Muscle Cells - Subclavian Artery, donor2 | 2.2 |
| CNhs14432 | COBL-a rinderpest infection, 48hr, biol_rep2 | 1.7 |
| CNhs12590 | Perineurial Cells, donor2 | 1.7 |
| CNhs13841 | iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2 | 1.6 |
| CNhs14444 | COBL-a rinderpest(-C) infection, 48hr, biol_rep1 | 1.1 |
| CNhs13840 | iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2 | 1.0 |
| CNhs12698 | K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2 | 0.9 |
| CNhs13326 | Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3) | 0.9 |
| CNhs12659 | MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2 | 0.8 |
| CNhs13379 | Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2) | 0.8 |
| CNhs14525 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3 | 0.8 |
| CNhs14618 | putamen, adult, donor10258 | 0.7 |
| CNhs14221 | medial frontal gyrus, adult, donor10258 | 0.6 |
| CNhs12610 | diencephalon, adult | 0.6 |
| CNhs14073 | occipital cortex, newborn, donor10223 | 0.6 |
| CNhs14437 | COBL-a rinderpest(-C) infection, 06hr, biol_rep3 | 0.6 |
| CNhs12664 | MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2 | 0.6 |
| CNhs12380 | chorionic membrane cells, donor3 | 0.5 |
| CNhs12925 | Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1) | 0.5 |
| CNhs12653 | MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2 | 0.5 |
| CNhs11844 | acantholytic squamous carcinoma cell line:HCC1806 | 0.4 |
| CNhs14059 | iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3 | 0.4 |
| CNhs12657 | MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2 | 0.4 |
| CNhs12684 | K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2 | 0.4 |
| CNhs12075 | Hepatic Sinusoidal Endothelial Cells, donor1 | 0.4 |
| SRX12709117 | Heart (Sample 108); the left and right atrial free wall, right and left ventricular base, and inferior and superior sinoatrial node | 0.4 |
| CNhs12061 | Fibroblast - Cardiac, donor6 | 0.4 |
| CNhs12663 | MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2 | 0.4 |
| CNhs12201 | CD8+ T Cells (pluriselect), donor090325, donation1 | 0.4 |
| CNhs14587 | Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1 | 0.4 |
| LShi10030_ACTTGA-CACTAGT | Human induced pluripotent stem cells grown on feeder-free condition, biol_rep2 | 0.4 |
| CNhs14604 | Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2 | 0.4 |
| CNhs14552 | medial temporal gyrus, adult, donor10258 | 0.4 |
| CNhi10939_ACG | Human primary dermal blood vascular endothelial cells, biol_rep1 | 0.4 |
| CNhs11718 | mesenchymal stem cell line:Hu5/E18 | 0.3 |
| CNhi10786_TAC | Human primary dermal fibroblasts derived from neonatal foreskin, biol_rep2 | 0.3 |
| CNhs14594 | Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1 | 0.3 |
| CNhs13051 | acute myeloid leukemia (FAB M5) cell line:P31/FUJ | 0.3 |
| SRX12709100 | Heart (Sample 93); the left and right atrial free wall, right and left ventricular base, and inferior and superior sinoatrial node | 0.3 |
| CNhs14480 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3 | 0.3 |
| CNhs13364 | Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20) | 0.3 |
| CNhs12950 | H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41) | 0.3 |
| CNhs13365 | Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23) | 0.3 |
| CNhs12949 | H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12) | 0.3 |
| CNhs12953 | Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15) | 0.3 |
| CNhs11943 | breast carcinoma cell line:MCF7 | 0.3 |
| CNhs12439 | MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1 | 0.3 |